GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Immunopharmacology Comments |
Xilonix is included in GtoImmuPdb as an immuno-oncology agent. The rationale for using anti-IL-1α antibodies to treat cancer is provided in patent US20100040574 [2]. |